Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Assets Average (2025 - 2026)

Beta Bionics' Assets Average history spans 2 years, with the latest figure at $316.6 million for Q1 2026.

  • On a quarterly basis, Assets Average rose 29.83% to $316.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $316.6 million, a 29.83% increase, with the full-year FY2025 number at $239.2 million, up 84.22% from a year prior.
  • Assets Average hit $316.6 million in Q1 2026 for Beta Bionics, down from $329.4 million in the prior quarter.
  • Over the last five years, Assets Average for BBNX hit a ceiling of $334.0 million in Q2 2025 and a floor of $243.8 million in Q1 2025.